Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

755
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
755
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.0K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

541
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
541
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

632
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
632

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.

Hepatology international·2023
Same author

Synergistic Photochemo Effects Based on Light-Activatable Dual Prodrug Nanoparticles for Effective Cancer Therapy.

Advanced healthcare materials·2023
Same author

PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.

Cancer research·2023
Same author

A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Journal of translational medicine·2022
Same author

Sorafenib-Loaded Cu<sub>2-x</sub>Se Nanoparticles Boost Photothermal-Synergistic Targeted Therapy against Hepatocellular Carcinoma.

Nanomaterials (Basel, Switzerland)·2022
Same author

Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma.

ACS applied materials & interfaces·2022

相关实验视频

Updated: Feb 6, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K

干细胞治疗炎症疾病:进展,挑战和未来方向

Chen Wu1, Zhi-Ping Jin2, Shu-Qiang Weng1

  • 1Department of Gastroenterology and Hepatology and Shanghai Institute of Liver Diseases Zhongshan Hospital Fudan University Shanghai China.

MedComm
|February 5, 2026
PubMed
概括

干细胞疗法为炎症性疾病提供了新的希望,针对性输送对局部疾病显示出最有前途. 最少加工的细胞疗法也显示出潜力,尽管需要进一步的研究才能广泛应用.

关键词:
造血干细胞是造血干细胞的组成部分.造血干细胞移植 造血干细胞移植诱导的多能干细胞干细胞.炎症性肠病是一种炎症性肠病.炎症性疾病是一种炎症性疾病.中介细胞干细胞中介细胞干细胞.

更多相关视频

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

696
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

相关实验视频

Last Updated: Feb 6, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.4K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

696
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

科学领域:

  • 再生医学是一种再生医学.
  • 免疫学 免疫学 免疫学
  • 胃肠病学 胃肠病学

背景情况:

  • 像IBD和RA这样的炎症性疾病带来了重大挑战,许多患者对当前的生物疗法没有反应.
  • 干细胞疗法提供了一种再生方法来解决这些疾病的复杂,多因素性质.
  • 现有的治疗方法往往无法完全恢复组织功能或解决潜在的疾病机制.

研究的目的:

  • 为了比较各种干细胞策略对炎症疾病的临床疗效.
  • 分析不同细胞来源和输送方法对治疗结果的影响.
  • 确定关键障碍,并提出解决方案,以推进该领域的干细胞治疗.

主要方法:

  • 系统审查和分析来自各种干细胞干预的临床结果.
  • 细胞源的比较评估,包括自身的和潜在的异构的选择.
  • 评估交付方法,重点是针对性与系统性方法.

主要成果:

  • 针对性传递系统在管理局部炎症病变和促进组织恢复方面表现出卓越的有效性.
  • 最少处理的细胞干预措施,如自主脂肪移植和树皮血管分离,显示出显著的治疗前景.
  • 仍然存在一些挑战,包括低于最佳的细胞定位,有限的植入和不完整的长期安全数据.

结论:

  • 优化干细胞疗法需要解决细胞定位和移植等转化障碍.
  • 先进的策略,包括诱导多能干细胞和基因修饰,对于未来的发展至关重要.
  • 本综述为基于证据的干细胞在耐火性炎症疾病中的应用提供了一个框架,为个性化再生医学铺平了道路.